SCHEMBL10513774

SCHEMBL10513774

CCCC(=O)c1cnc2c(C(C)O)cccc2c1Nc1ccc(O)cc1C.CCCC(=O)c1cnc2c(C=O)cccc2c1Nc1ccc(O)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9267855 0.93 — —
SCHEMBL9268862 0.92 — —
SCHEMBL10512779 0.90 — —
SCHEMBL9271993 0.86 — —
Hydrochloric Acid SCHEMBL10532400 0.85 — —
Hydrochloric Acid SCHEMBL10532361 0.85 — —
SCHEMBL9264580 0.83 ATP4A (0.70) —
SCHEMBL10514598 0.83 — —
SCHEMBL9272700 0.82 ATP4A (0.71) —
SCHEMBL9506370 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0330485-A1 4-Amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion SmithKline Beecham Intercredit B.V. (NL) 1989-08-30 — — EP disclosed
Send feedback